Semnur Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch SMNR and buy or sell other stocks, ETFs, and their options commission-free!About SMNR
Semnur Pharmaceuticals, Inc. is a late-stage clinical biopharmaceutical company focused on developing and commercializing innovative non-opioid pain management products for the treatment of acute and chronic pain. Its lead product candidate, SP-102, is a non-opioid novel injectable corticosteroid gel formulation for patients with moderate to severe lumbosacral radicular pain.
CEOJaisim Shah
CEOJaisim Shah
Employees2
Employees2
HeadquartersPalo Alto, California
HeadquartersPalo Alto, California
Founded
Founded
Employees2
Employees2
SMNR Key Statistics
Market cap2.07B
Market cap2.07B
Price-Earnings ratio-7.43
Price-Earnings ratio-7.43
Dividend yield—
Dividend yield—
Average volume0.33
Average volume0.33
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$20.00
52 Week high$20.00
52 Week low$9.00
52 Week low$9.00
Stock Snapshot
Semnur Pharmaceuticals(SMNR) stock is priced at $9.00, giving the company a market capitalization of 2.07B. It carries a P/E multiple of -7.43.
On 2025-12-05, Semnur Pharmaceuticals(SMNR) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Semnur Pharmaceuticals(SMNR) stock has reached 0, versus its average volume of 0.33.
The stock's 52-week range extends from a low of $9.00 to a high of $20.00.
The stock's 52-week range extends from a low of $9.00 to a high of $20.00.